Distinct mechanisms of loss of estrogen receptor α gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors

Carcinogenesis

Volumn 21, Issue 12, 2000, Pages 2193-2201

  Yoshida, Takashi ^a,c   Eguchi, Hidetaka ^a   Nakachi, Kei ^a   Tanimoto, Keiji ^b   Higashi, Yasuhiro ^a   Suemasu, Kimito ^a   Iino, Yuichi ^c   Morishita, Yasuo ^c   Hayashi, Shin Ichi ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; BIOASSAY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL ACTIVITY; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REGULATORY MECHANISM; REPORTER GENE;

BASE SEQUENCE; BREAST NEOPLASMS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INTRONS; LUCIFERASES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFITES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034522739     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
2. Toward a physiological approach to breast cancer prevention
3. The loss of estrogen and progesterone receptor gene expression in human breast cancer
4. Evidence for a previously unidentified upstream exon in the human estrogen receptor gene
5. Sequencing of an RNA transcript of the human estrogen receptor gene: Evidence for a new transcriptional event
6. Localization of DNase hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters
7. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer
8. Regulation of estrogen receptor gene mediated by promoter B responsible for its enhanced expression in human breast cancer
9. CpG-rich islands and function of DNA methylation
10. Alterations in DNA methylation may play a variety of roles in carcinogenesis
11. Mechanisms of inactivation of E-cadherin in breast cancer cell lines
12. Methylation of the BRCA1 gene in sporadic breast cancer
13. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
14. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
15. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors
16. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines
17. Methylation of the estrogen receptor CpG island marks loss of estrogen receptor expression in human breast cancer cells
18. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells
19. Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction
20. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactive estrogen receptor gene expression
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Mast cell-/basophil-specific transcriptional regulation of human L-histidine decarboxylase gene by CpG methylation in the promoter region
23. High sensitivity mapping of methylated cytosines
24. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
25. Methylation specific PCR: A novel PCR assay for methylation status of CpG islands
26. Methylation of the 5' CpG Island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas
27. Molecular cloning of the human AH receptor gene promoter
28. Stability of patch methylation and its impact in regions of transcriptional initiation and elongation
29. Inhibition of DNA methylation by 5-Aza-2′-deoxycytidine suppresses the growth of human tumor cell lines
30. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer
31. Increased cytosine DNA-methyltransferase activity during colon cancer progression
32. Identifying 5-methylcytosine and related modifications in DNA genomes
33. Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma
34. Transcriptional regulation of estrogen receptor in breast carcinomas
35. Identification of ERF-1 as a member of the AP2 transcription factor family
36. A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers
37. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs
38. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
39. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
40. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex